Why 2016 was a positive year for psychedelic drugs being used as medicine

“If compassion for the suffering of the patients fails to overcome the taboo, then perhaps financial advantage to Health Services will. The evidence is building up that more can be achieved in one session with these compounds than through years of psychotherapy.”

Research currently underway includes an investigation into whether psychedelics can treat nicotine addiction, and promoting neurogenesis to aid those with Alzheimer’s. “Psychedelics seem able to shake this rigidity and reset the connections into more positive patterns of thought and behaviour,” suggested Feilding. While she understands that people are afraid of drugs and admits they can be misused and cause harm – taken incorrectly psychedelics can trigger mental illnesses and recurring hallucinations – she believes it is wrong to prohibit them “because when there is a desire, there will always be a way.” Instead, she backs strict regulation and a “common-sense” approach….“We need to change their classification so that scientific research can be carried on without amazing and vastly expensive obstacles, and so that physicians can prescribe them where appropriate.”,,,,”We have also reached a tipping point as to how psychedelics are reported in the media. The stigma surrounding the subject is falling away, and a serious conversation about psychedelics is no longer completely taboo. The future is bright, if only we allow it to happen.”

Original Article (Independent):
Why 2016 was a positive year for psychedelic drugs being used as medicine
Artwork Fair Use: Alex Proimos

1 Comment

Leave a Reply